The DOI matches its Crossref record; 290 of the 291 references it cites were found in a registry or an index.
Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging
Open accessAbstract
Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) resets their identity back to an embryonic age and, thus, presents a significant hurdle for modeling late-onset disorders. In this study, we describe a strategy for inducing aging-related features in human iPSC-derived lineages and apply it to the modeling of Parkinson's disease (PD). Our approach involves expression of progerin, a truncated form of lamin A associated with premature aging. We found that expression of progerin in iPSC-derived fibroblasts and neurons induces multiple aging-related markers and characteristics, including dopamine-specific phenotypes such as neuromelanin accumulation. Induced aging in PD iPSC-derived dopamine neurons revealed disease phenotypes that require both aging and genetic susceptibility, such as pronounced dendrite degeneration, progressive loss of tyrosine hydroxylase (TH) expression, and enlarged mitochondria or Lewy-body-precursor inclusions. Thus, our study suggests that progerin-induced aging can be used to reveal late-onset age-related disease features in hiPSC-based disease models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, induction of pluripotency in iPSCs resets the age signatures of the donor cells to a fetal stage (7–9).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Progerin has been previously demonstrated to induce late-onset age-related disease features in human iPSC-based disease models112.”
From GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau (2025) · cites this paper as [112]
In the citing paper
“Cellular aging features (Huh et al., 2016; Mertens et al., 2015a, 2018; Tang et al., 2017; Victor et al., 2014) and adult-like neuronal identity of iNs (Luo et al., 2019) are likely critical for the emergence of such phenotypes in sporadic AD neurons, because erasure of aging signatures and re-gaining of fetal identity represents a potent rescue in this study (Miller et al., 2013; Ocampo et al., 2”
From Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer’s patients (2021) · cites this paper as Miller et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz‐Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,947
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Flagged first, then by citations
1 of the 291 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 781
Can accelerated ageing models inform us on age‐related tauopathies?
Han, Z. Z., Fleet, A., & Larrieu, D. (2023) · Aging Cell · doi:10.1111/acel.13830 · Cited by 10
Assoni, A. F., Guerrero, E. N., Wardenaar, R., Oliveira, D., Bakker, P. L., Alves, L. M., Carvalho, V. M., Okamoto, O. K., Zatz, M., & Foijer, F. (2023) · Brain Pathology · doi:10.1111/bpa.13206 · Cited by 8
Development of an accelerated cellular model for early changes in Alzheimer’s disease
Xue, H., Gate, S., Gentry, E., Losert, W., & Cao, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-45826-5 · Cited by 8
Modeling hypothalamic pathophysiology in vitro for metabolic, circadian, and sleep disorders
Leal, H., Carvalhas-Almeida, C., Álvaro, A. R., & Cavadas, C. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.01.001 · Cited by 9
Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Calvo, B., Schembri-Wismayer, P., & Alonso, M. B. D. (2025) · Cells · doi:10.3390/cells14050347 · Cited by 9
Utilization of stem cells to model Parkinson's disease – current state and future challenges
Hillje, A., & Schwamborn, J. C. (2016) · Future Neurology · doi:10.2217/fnl.16.7 · Cited by 7
Cellular reprogramming: A new way to understand aging mechanisms
İlçe, B. Y., Cagin, U., & Yılmazer, A. (2018) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.308 · Cited by 8
Liang, K. X., Kristiansen, C. K., Vatne, G. H., Hong, Y., & Bindoff, L. A. (2020) · Cell and Tissue Research · doi:10.1007/s00441-019-03164-x · Cited by 8
Pandya, V. A., Crerar, H., Mitchell, J. S., & Patani, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063256 · Cited by 10
Calamini, B., Geyer, N., Huss-Braun, N., Bernhardt, A., Harsany, V., Rival, P., Cindhuchao, M., Hoffmann, D., & Gratzer, S. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048017 · Cited by 8
Matt, S. M. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100353 · Cited by 8
Maheshwari, S., Vilema-Enríquez, G., & Wade‐Martins, R. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00376-8 · Cited by 10
Huang, X., Pan, Y., Cao, D., Fang, S. C., Huang, K., Chen, J., & Chen, A. (2017) · Oncology Reports · doi:10.3892/or.2017.5603 · Cited by 8
In Vitro Modeling of Leucine-Rich Repeat Kinase 2 G2019S-Mediated Parkinson's Disease Pathology
Vermilyea, S., & Emborg, M. E. (2018) · Stem Cells and Development · doi:10.1089/scd.2017.0286 · Cited by 9
Lam, I., Ndayisaba, A., Lewis, A. J., Fu, Y., Sagredo, G. T., Zaccagnini, L., Sandoe, J., Sanz, R. L., Vahdatshoar, A., Martin, T. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.08.515615 · Cited by 8
In vitro liver models for toxicological research
Fukunaga, I., & Takebe, T. (2025) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2025.101478 · Cited by 7
Wu, Y., Zhong, A., Evangelisti, A., Sidharta, M., Huangfu, D., Studer, L., & Zhou, T. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102499 · Cited by 7
Self-citationChae, U., Yang, H.-J., Kim, H., Lee, S. H., Lee, D. G., Koo, J. Y., Ha, S.-M., Bak, S. P., Joo, M., Nam, H. H., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.06.017 · Cited by 10
Experimental models for ageing research.
Toniolo, L., Sirago, G., & Giacomello, E. (2023) · PubMed · doi:10.14670/hh-18-576 · Cited by 9
Santarriaga, S., Gerlovin, K., Layadi, Y., & Karmacharya, R. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.02.029 · Cited by 7
Stem Cell-Based Approaches in Parkinson's Disease Research
Kim, M. S., Yoon, S., Choi, J., Kim, Y. J., & Lee, G. (2024) · International Journal of Stem Cells · doi:10.15283/ijsc23169 · Cited by 7
Barbaric, I., Allison, T. F., Powles-Glover, N. S., Biga, V., & Andrews, P. W. (2015) · International Journal of High Throughput Screening · doi:10.2147/ijhts.s58113 · Cited by 7
Manipulating cell fate while confronting reproducibility concerns
Osterloh, J. M., & Mullane, K. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.016 · Cited by 7
The San Diego Nathan Shock Center: tackling the heterogeneity of aging
Shadel, G. S., Adams, P. D., Berggren, W. T., Diedrich, J. K., Diffenderfer, K. E., Gage, F. H., Hah, N., Hansen, M., Hetzer, M. W., Molina, A. J. A., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00426-x · Cited by 7
Towards elucidating disease-relevant states of neurons and glia by CRISPR-based functional genomics
Leng, K., & Kampmann, M. (2022) · Genome Medicine · doi:10.1186/s13073-022-01134-7 · Cited by 7
An analogue of the Prolactin Releasing Peptide reduces obesity and promotes adult neurogenesis
Jörgensen, S. K. M., Karnošová, A., Mazzaferro, S., Rowley, O., Chen, H. C., Robbins, S. J., Christofides, S. R., Merkle, F. T., Maletı́nská, L., & Petřík, D. (2023) · EMBO Reports · doi:10.1038/s44319-023-00016-2 · Cited by 7
Kitaeva, K. V., Solovyeva, V. V., Blatt, N. L., & Rizvanov, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010643 · Cited by 7
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips
Buck, F., Bugter, J., Yorukoglu, G., Dastjerd, M. K., & Winkler, T. E. (2026) · Advanced Biology · doi:10.1002/adbi.202500536 · Cited by 6
α-synuclein pathogenesis in hiPSC models of Parkinson’s disease
Baena-Montes, J. M., Avazzadeh, S., & Quinlan, L. R. (2021) · Neuronal Signaling · doi:10.1042/ns20210021 · Cited by 6
Luo, H., Xu, J. L., Huang, D., Chen, Y.-Q., Liu, Y., Li, Y., & Chen, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1030390 · Cited by 9
Hutchinson-Gilford progeria syndrome: Cardiovascular manifestations and treatment
Lian, J., Du, L., Li, Y., Yin, Y., Yu, L., Wang, S., & Ma, H. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111879 · Cited by 8
Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease
Finkbeiner, S. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105088 · Cited by 8
Induced Pluripotent Stem Cells, a Stepping Stone to In Vitro Human Models of Hearing Loss
Alonso, M. B. D., & Petković, H. (2022) · Cells · doi:10.3390/cells11203331 · Cited by 6
Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival
Cui, J., Carey, J., & Pera, R. A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1026468 · Cited by 6
Aged and Diseased Neurons Get Lost in Transport
Tamburrino, A., & Decressac, M. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.02.007 · Cited by 6
Modeling neurodegenerative disorders in adult somatic cells: A critical review
Truong, A. N., Si, E., Duncan, T., & Valenzuela, M. (2016) · Frontiers in Biology · doi:10.1007/s11515-016-1413-3 · Cited by 6
Patrón, L. A., ICAGEN, 2. E. I. P. D., & August, P. R. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2018.2.91 · Cited by 6
Cell-based Research and Therapy for Amyotrophic Lateral Sclerosis: Promises and Challenges
Vasques, J. F., Teixeira‐Pinheiro, L. C., Gonçalves, R. G. D. J., Méndez‐Otero, R., & Gubert, F. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.amyotrophiclateralsclerosis.celltherapy.2021 · Cited by 6
Brain aging, Alzheimer's disease, and the role of stem cells in primate comparative studies
August, I., Semendeferi, K., & Marchetto, M. C. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25394 · Cited by 6
hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges
Lukovic, D., Moreno‐Manzano, V., Rodríguez-Jiménez, F. J., Vilches, A., Syková, E., Jendelová, P., Stojković, M., & Erceg, S. (2016) · The Neuroscientist · doi:10.1177/1073858416672652 · Cited by 6
Zink, A., Priller, J., & Prigione, A. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.005 · Cited by 6
Benitez, J. A., Cheng, S., Kee, N., Cao, M., Wang, M., Deng, Q., & Hedlund, E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/334417 · Cited by 6
Naffaa, M. M. (2025) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-25-00013 · Cited by 5
iPSC-derived neural organoids in dementia research: Recent advances and future directions
Shima, S., Kondo, T., & Inoue, H. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104980 · Cited by 6
Carr, L. M., Mustafa, S., Care, A., & Collins‐Praino, L. E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.023 · Cited by 5
Vandiver, A. R., Torres, A., Sanden, A., Nguyen, T. L., Gasilla, J., Doan, M. T., Martirosian, V., Hoang, A. N., Wanagat, J., & Teitell, M. A. (2024) · Aging Cell · doi:10.1111/acel.14402 · Cited by 6
Elder, N. H., Fattahi, F., McDevitt, T. C., & Zholudeva, L. V. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.962103 · Cited by 6
Human Brain Banking as a Convergence Platform of Neuroscience and Neuropsychiatric Research
Liu, F., Yin, X., Cong, C., Wang, Y., & Ma, C. (2022) · Human Brain · doi:10.37819/hb.001.001.0204 · Cited by 5
McCaughey‐Chapman, A., Tarczyluk, M. A., Combrinck, C., Edwards, N., Jones, K., & Connor, B. J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1003188 · Cited by 7
Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons
Otero, M. G., Bell, S., Laperle, A., Lawless, G. M., Myers, Z., Castro, M. A., Villalba, J. M., & Svendsen, C. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814227 · Cited by 5
Huber, A., Sarne, V., Beribisky, A. V., Ackerbauer, D., Derdak, S. V., Madritsch, S., Etzler, J., Huck, S., Scholze, P., Görgülü, I., et al. (2024) · Stem Cells and Development · doi:10.1089/scd.2023.0233 · Cited by 5
Direct Conversion Provides Old Neurons from Aged Donor’s Skin
Koch, P. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.11.009 · Cited by 6
Hendrickx, D. M., & Glaab, E. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00761-6 · Cited by 5
Detection of Soluble and Insoluble Protein Species in Patient-Derived iPSCs
Santarriaga, S., Luecke, I. W., & Ebert, A. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1979-7_6 · Cited by 5
Transcription Factors of Direct Neuronal Reprogramming in Ontogenesis and Ex Vivo
Samoilova, E. M., Викторович, Б. В., & Baklaushev, V. P. (2021) · Molecular Biology · doi:10.1134/s0026893321040087 · Cited by 5
Age-induced midbrain-striatum assembloids model early phenotypes of Parkinson’s diseasePreprint
Barmpa, K., Saraiva, C., Gomez‐Giro, G., Gabassi, E., Spitz, S., Brandauer, K., Rodriguez-Gatica, J. E., Antony, P. M. A., Robertson, G., Papastefanaki, F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.28.564305 · Cited by 5
Kim, T. W., Piao, J., Bocchi, V. D., Koo, S. Y., Choi, S. J., Chaudhry, F. F., Yang, D., Cho, H., Hergenreder, E., Perera, L. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.06.631400 · Cited by 5
Self-citationPuspita, L., Deline, M., & Shim, J. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100284 · Cited by 5
Self-citationТранскрипционные факторы прямого пронейронального репрограммирования в онтогенезе и ex vivo
Samoilova, E. M., Викторович, Б. В., & Baklaushev, V. P. (2021) · Molecular Biology · doi:10.31857/s0026898421050086 · Cited by 4
Fountain of youth—Targeting autophagy in aging
Danics, L., Abbas, A. A., Kis, B., & Pircs, K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1125739 · Cited by 4
The role of glial cells in amyotrophic lateral sclerosis
Pandya, V. A., & Patani, R. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.005 · Cited by 5
Induced pluripotent stem cells for modeling and cell therapy of Parkinson′s disease
Dani�ovič, Ľ., Csöbönyeiová, M., & Polák, Š. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.182692 · Cited by 4
Knock, E., & Julian, L. M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.767457 · Cited by 5
Böhnke, L., Zhou-Yang, L., Pelucchi, S., Kogler, F., Frantal, D., Schön, F., Lagerström, S., Borgogno, O., Baltazar, J., Herdy, J. R., et al. (2022) · Cellular Reprogramming · doi:10.1089/cell.2021.0200 · Cited by 5
Accelerated neuronal aging in vitro ∼melting watch ∼
Inagaki, E., Yoshimatsu, S., & Okano, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.868770 · Cited by 4
Kovalenko, V., Александровна, Х. Е., Рзаев, Д. А., & Medvedev, S. P. (2017) · Genes and Cells · doi:10.23868/201707012 · Cited by 4
Gopurappilly, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_643 · Cited by 4
Jang, Y., & Jung, J. H. (2017) · Biomedical Dermatology · doi:10.1186/s41702-017-0004-5 · Cited by 4
Human Stem Cell–Derived Models: Lessons for Autoimmune Diseases of the Nervous System
Harschnitz, O. (2018) · The Neuroscientist · doi:10.1177/1073858418777999 · Cited by 4
Garber, K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2977 · Cited by 4
Bocchi, V. D., To, K., Weber, L., Zumbo, P., Kim, L., Shida, I. Y., Yang, D., Storm, P., Fiorenzano, A., Sozzi, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.19.733041 · Cited by 4
Self-citationHolloway, K., Neherin, K., Song, Y., Sato, K., Houston, A., Chen, F., Li, D., & Zhang, H. (2025) · Aging Cell · doi:10.1111/acel.14472 · Cited by 3
Jeon, S., Park, C., Hong, J., Kim, J., Lee, Y. J., Hur, J. K., & Lee, J. Y. (2025) · Aging Cell · doi:10.1111/acel.70143 · Cited by 3
Bury, A. G., Olejnik, A., Tocco, C., Saurat, N. G., Stephen, E., Hockemeyer, D. F., Schwamborn, J. C., Studer, L., Mastroberardino, P. G., Bolognin, S., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01137-2 · Cited by 4
Self-citationKarlsson, O., Pandiloski, N., Horváth, V., Adami, A., Garza, R., Johansson, P. A., Johansson, J., Douse, C. H., & Jakobsson, J. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag100 · Cited by 3
Escobedo, S. E., McGovern, S. E., Jauregui-Lozano, J. P. P., Stanhope, S. C., Anik, P., Singhal, K., DeBernardis, R., & Weake, V. M. (2023) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2023.1187980 · Cited by 5
Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes
Kraskovskaya, N., Linkova, N. S., Sakhenberg, E. I., Kriger, D. V., Polyakova, V. O., Медведев, Д. С., Krasichkov, A. S., Георгиевич, Х. М., & Ryzhak, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111363 · Cited by 4
Brain organoids and genome editing: A new era in understanding human brain development and disorders
Zhou, M., Cao, Y., Yue, K., Wu, W., Xie, Y., Hu, D., Zhao, J., Xu, F., Guo, J., Li, Z., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01546 · Cited by 3
Induced pluripotent stem cell technology: venturing into the second decade
Shi, Y., Inoue, H., Takahashi, J. B., & Yamanaka, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00095-2 · Cited by 4
Chen, Y., Jong, T., Chen, C., & Sidransky, E. (2022) · Movement Disorders · doi:10.1002/mds.28998 · Cited by 3
Applications of Induced Pluripotent Stem Cell-Derived Glia in Brain Disease Research and Treatment
Yang, Z., Gong, M., Yang, C., Chen, C., & Zhang, K. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_697 · Cited by 3
Angeles, A. D. L., & Tunbridge, E. M. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0017 · Cited by 3
Sauerzopf, U., Sacco, R., Novarino, G., Niello, M., Weidenauer, A., Praschak-Rieder, N., Sitte, H. H., & Willeit, M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13418 · Cited by 3
hiPSC-Based Tissue Organoid Regeneration
Qu, Y., Yucer, N., Garcia, V. J., Giuliano, A. E., & Cui, X. (2018) · InTech eBooks · doi:10.5772/intechopen.76997 · Cited by 3
The Causative and Curative Roles of Brain-Derived Neurotrophic Factor in Parkinson’s Disease
Hernández-Baltazar, D., Nadella, R., Llanderal, T. C., Puga-Olguín, A., Barrientos-Bonilla, A. A., Zavala-Flores, L. M., Villanueva-Olivo, A., Sánchez-García, A. D. C., Rovirosa-Hernández, M. D. J., & Rembao-Bojórquez, J. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81215 · Cited by 4
The application of iPSCs in Parkinson’s disease
Nielsen, J. J. J., Lillethorup, T. P., Glud, A. N., Sørensen, J. C. H., & Orłowski, D. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-024 · Cited by 3
Mahmoudi, S., Mancini, E., Moore, A. L., Xu, L., Jahanbani, F., Hebestreit, K., Srinivasan, R., Li, X., Devarajan, K., Prélot, L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/448431 · Cited by 3
Sorek, M., Oweis, W., Nissim‐Rafinia, M., Maman, M., Simon, S., Hession, C. C., Adiconis, X., Simmons, S., Sanjana, N. E., Shi, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.02.398263 · Cited by 3
Pircs, K., Drouin‐Ouellet, J., Gil, J., Rezeli, M., Grassi, D. A., Garza, R., Sharma, Y., St‐Amour, I., Jönsson, M. E., Johansson, P. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.01.433433 · Cited by 3
Drouin‐Ouellet, J., Pircs, K., Legault, E. M., Birtele, M., Nilsson, F., Shrigley, S., Pereira, M., Storm, P., Sharma, Y., Vuono, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.441070 · Cited by 3
Zhang, C., Saurat, N. G., Cornacchia, D., Chung, S. Y., Sikder, T., Minotti, A. P., Studer, L., & Betel, D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.03.547539 · Cited by 3
Self-citationGaranin, A. A., Громова, О. А., & Bogacheva, T. E. (2025) · Pharmacokinetics and Pharmacodynamics · doi:10.37489/2587-7836-2024-4-17-21 · Cited by 2
Gentry, E., Islam, M. T., Xue, H., Cao, K., & Nemes, P. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101490 · Cited by 2
Maskell, K. G., Cook, A. L., King, A. E., Dickson, T. C., & Blizzard, C. L. (2026) · Lab on a Chip · doi:10.1039/d5lc00577a · Cited by 2
Neherin, K., Holloway, K., Song, Y., Houston, A., Chen, F., Ding, L., & Zhang, H. (2026) · Advanced Biology · doi:10.1002/adbi.202500468 · Cited by 2
Organoid–microglia system for modeling the immune microenvironment of the brain and retina
Yu, J., Tang, B., Gu, Z., Wang, G., & Liu, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1747589 · Cited by 2
Human pluripotent stem cell engineering with CRISPR–Cas9 for Parkinson’s disease
Park, S. B., Kim, J., Ha, Y., Kim, M. S., & Kim, T. W. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01679-2 · Cited by 2
Translating Alzheimer’s disease proteomics into drug discovery opportunities
Drummond, E., Werry, E. L., Kavanagh, T., Genoud, S., Cho, A., Chen, S., Du, J., Hibbs, D. E., & Kassiou, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00035-y · Cited by 2
Cheung, N. (2026) · Cureus · doi:10.7759/cureus.111824 · Cited by 3
Metadata
- Authors
- Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., Taldone, T., Fusaki, N., Tomishima, M. J., Krainc, D., Milner, T. A., Rossi, D. J., & Studer, L.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Boston Children's Hospital (US)
- Keio University (JP)
- Harvard University (US)
- Weill Cornell Medicine (US)
- Corresponding author
- Studer, Lorenz
- ORCID
- Venue
- Cell stem cell
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 13
- Issue
- 6
- Pages
- 691-705
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- PMC
- PMC4153390
- OpenAlex
- W2081914422
- Cited by
- 777
- References
- 291
- Citations by year
- 2026: 46 · 2025: 41 · 2024: 52 · 2023: 54 · 2022: 50 · 2021: 71 · 2020: 66 · 2019: 64 · 2018: 76 · 2017: 72 · 2016: 94 · 2015: 52 · 2014: 38 · 2013: 1
- FWCI
- 27.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell stem cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- New York Stem Cell Foundation
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL-098351, R01HL098351)
- National Institute on Drug Abuse (R01DA008259, DA08259)
- National Cancer Institute (F31CA167863, P30CA008748)
- National Institute of Neurological Disorders and Stroke (NS078338, U24NS078338, R01NS052671, R01NS076054, NS076054)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- progerin, lamin A, premature aging, induced pluripotent stem cells, Parkinson's disease, late-onset disease, iPSC-derived fibroblasts, dendrite degeneration, tyrosine hydroxylase, Lewy bodies, mitochondrial enlargement, disease modeling
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Animals, Cell Differentiation, Child, Fibroblasts, Humans, Mesencephalon, Middle Aged, Models, Biological, Nuclear Proteins, Parkinson Disease, Phenotype, Protein Precursors, Tissue Donors, Biomarkers, Cellular Senescence, Age of Onset, Lamin Type A, Mice, Induced Pluripotent Stem Cells, Dopaminergic Neurons, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
